On a DART-filed basis, annual revenue fell 15.5% from KRW 162 billion in 2022 to KRW 136.9 billion in 2023, then rose 3.8% to KRW 142.1 billion in 2024 and 8.1% to KRW 153.6 billion in 2025.
Operating profit fell from KRW 14.5 billion in 2022 (8.9% margin) to KRW 13.6 billion in 2023 (9.9% margin), then dropped to KRW 6.2 billion in 2024 (4.4% margin, down 54.3%).
In 2025 the company swung to an operating loss of KRW 142 million (-0.1% margin), and it attributed this to higher fixed costs from the HAIMK plant under construction and lower sales of high-margin UC products.
Profit attributable to controlling shareholders peaked at KRW 12.2 billion in 2023 (up 44.6%), fell to KRW 5.67 billion in 2024 (down 53.3%), and reached KRW 435 million in 2025 (down 92.3%).
Net loss including non-controlling interests was KRW 1.01 billion in 2025, so the gap with the positive controlling-shareholder figure reflects losses booked on the non-controlling side.
At end-2025, total equity was KRW 206.1 billion, of which KRW 185.1 billion belonged to controlling shareholders, and total liabilities were KRW 68.5 billion. The debt ratio rose from 22.2% in 2024 to 33.2% in 2025, and operating cash flow moved from KRW -10.9 billion in 2024 to KRW 5.64 billion in 2025.
Quarterly revenue rose from KRW 38.5 billion in Q3 2025 to KRW 40.6 billion in Q4 2025, with Q4 turning to an operating profit of KRW 1.11 billion.
Q1 2026 revenue of KRW 43.1 billion came with an operating loss of KRW 1.15 billion, Q2 2026 revenue of KRW 51.3 billion came with an operating profit of KRW 533 million, and Q3 2026 revenue of KRW 56.9 billion came with an operating loss of KRW 347 million.
Profit attributable to controlling shareholders was KRW 101 million in Q3 2026, down 84.8% from the prior quarter, and totaled KRW 1.29 billion over the last four quarters. Revenue has risen for four straight quarters, but that growth has not yet carried into a higher operating margin.